Erratum to "Detection of anti-heat shock protein 90 β (Hsp90β) antibodies in cerebrospinal fluid" [Journal of Immunological Methods, volume 318, issues 1-2, 10 January 2007, pages 153-157] (DOI:10.1016/j.jim.2006.09.017);Detection of anti-heat shock protein 90 β (Hsp90β) antibodies in cerebrospinal fluid

Journal of Immunological Methods

Volumn 318, Issue 1-2, 2007, Pages 153-157

  Cid, C ^a,b   Garcia Villanueva M ^a   Salinas, M ^a   Alcazar A ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b CENTRO DE ASTROBIOLOGÍA CSIC INTA   (Spain)

Author keywords

Autoantibodies; Cell membrane; Cerebrospinal fluid; Hsp90; Multiple sclerosis; Western blot

Indexed keywords

AUTOANTIBODY; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 BETA; HEAT SHOCK PROTEIN 90 BETA ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CELL MEMBRANE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; OLIGODENDROGLIA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; STEM CELL; WESTERN BLOTTING;

EID: 33845865788     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2007.02.004     Document Type: Erratum

References (10)

1. Bielekova B., and Martin R. Development of biomarkers in multiple sclerosis. Brain 127 (2004) 1463
2. Cid C., Álvarez-Cermeño J.C., Camafeita E., Salinas M., and Alcázar A. Antibodies reactive to heat shock protein 90 induce oligodendrocyte precursor cell death in culture. Implications for demyelination in multiple sclerosis. FASEB J. 18 (2004) 409
3. Cid C., Álvarez-Cermeño J.C., Salinas M., and Alcázar A. Anti-heat shock protein 90 b antibodies decrease pre-oligodendrocyte population in perinatal and adult cell cultures. Implications for remyelination in multiple sclerosis. J. Neurochem. 95 (2005) 349
4. Hayem G., De Brand M., Palazzo E., Rouxd S., Combe B., Eliaou J.F., Sany J., Kahn M.F., and Meyer O. Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis. Ann. Rheum. Dis. 58 (1999) 291
5. McDonald W.I., Compston A., Edan G., Googkin D., Hartung H.P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley A., Thompson A., Van den Noort S., Weinshenker B.Y., and Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121
6. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343 (2000) 938
7. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., and Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13 (1983) 227
8. Qin H.Y., Mahon J.L., Atkinson M.A., Chaturvedi P., Lee-Chan E., and Singh B. Type 1 diabetes alters anti-hsp90 autoantibody isotype. J. Autoimmun. 20 (2003) 237
9. Ripley B.J., Isenberg D.A., and Latchman D.S. Elevated levels of the 90 kDa heat shock protein (hsp90) in SLE correlate with levels of IL-6 and autoantibodies to hsp90. J. Autoimmun. 17 (2001) 341
10. Roy N.S., Wang S., Harrison-Restelli C., Benraiss A., Fraser R.A.R., Gravel M., Braun P.E., and Goldman S.A. Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter. J. Neurosci. 19 (1999) 9986